We are live on ! Find out more
XBIT icon

XBiotech
XBIT

46 hedge funds and large institutions have $58.4M invested in XBiotech in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 2

700% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 2

368% more capital invested

Capital invested by funds: $12.5M → $58.4M (+$45.9M)

44% more funds holding

Funds holding: 32 → 46 (+14)

Holders
46
Holders Change
+14
Holders Change %
+43.75%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
24
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$5.1M
2
State Street
State Street
Massachusetts
+$2.98M
3
Northern Trust
Northern Trust
Illinois
+$2.11M
4
BIT
BlackRock Institutional Trust
California
+$1.94M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.52M

Top Sellers

Rank Fund Capital Flow
1
AA
ALPS Advisors
Colorado
-$342K
2
GCP
GSA Capital Partners
United Kingdom
-$162K
3
Citigroup
Citigroup
New York
-$24.3K
4
TRCT
Tower Research Capital (TRC)
New York
-$18.5K

XBIT Hedge Fund Activity: Q2 2016 in Review

46 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q2 2016, worth a combined $58.4M — up 368% from $12.5M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new XBIT positions and 2 closed out — a net gain of 14 holders — while 24 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $5.1M. The largest seller was ALPS Advisors, exiting entirely with an estimated $342K sold.

  • 46 institutional investors held XBiotech (XBIT) as of Q2 2016, up from 32 in Q1 2016.
  • Funds reported $58.4M of XBiotech stock for Q2 2016, up 368% quarter-over-quarter.
  • 16 funds opened new XBiotech positions in Q2 2016 and 2 closed out, a net change of +14 holders.
  • The largest XBiotech buyer in Q2 2016 was BlackRock Fund Advisors, an estimated $5.1M added.
  • The largest XBiotech seller in Q2 2016 was ALPS Advisors, an estimated $342K sold.

Based on aggregated 13F filings for Q2 2016.